Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 19124 | BI-3812 | 2166387-64-8 | >98% |  |
| BI-3812 is a potent inhibitor of the interaction of the BTB/POZ domain of BCL6 with s | ||||
| 1812286 | BAY 678 | 675103-36-3 | >98% |  |
| BAY 678 is a potent and selective cell-permeable human neutrophil elastase (HNE) inhi | ||||
| 1812261 | BN-82002 | 396073-89-5 | >98% |  |
| BN-82002, also known as CDC25 Phosphatase Inhibitor I, is a cell-permeable ortho-hydr | ||||
| 1811291 | BMS-509744 | 439575-02-7 | >98% |  |
| BMS-509744 is a potent interleukin-2 inducible T cell kinase (ITK) inhibitor (IC50 = | ||||
| 1811281 | BMS-688521 | 893397-44-9 | >98% |  |
| BMS-688521 is a small molecule antagonist of leukocyte function associated antigen-1 | ||||
| 1811264 | BMS-986195 | 1912445-55-6 | >98% |  |
| BMS-986195 is a potent, covalent, irreversible inhibitor of Bruton’s tyrosine kinas | ||||
| 1811262 | BAY-299 | 2080306-23-4 | >98% |  |
| BAY-299 is a potent and selective BRD1 and TAF1 inhibitor (IC50 values are 6 and 13 n | ||||
| 1810163 | BMS-986165 | 1609392-27-9 | >99% |  |
| BMS-986165 potently binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM). BMS-986165 | ||||
| 187181 | Bictegravir | 1611493-60-7 | >98% |  |
| Bictegravir, also known as GS-9883, is a potent, unboosted, once-Daily HIV-1 Integras | ||||
| 187121 | Basimglurant | 1034442-21-1 | >98% |  |
| Basimglurant, also known as RO 4917523 and RG-7090, is a novel mGlu5 negative alloste | ||||
| 186232 | 3BDO | 890405-51-3 | >98% |  |
| 3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling | ||||
| 185314 | BMS-986205 | 1923833-60-6 | >98% |  |
| BMS-986205 is an anticancer drug candidate. | ||||
| 185182 | Birinapant | 1260251-31-7 | >98% |  |
| Birinapant, also known as TL32711, is a synthetic small molecule and peptido mimetic | ||||
| 18573 | Bryostatin 1 | 83314-01-6 | >98% |  |
| Bryostatin 1 is a potent Protein Kinase C modulator isolated from the bryozoan Bugula | ||||
| 1842812 | BMS-813160 | 1286279-29-5 | >98% |  |
| BMS-813160 is a potent and selective CCR2/CCR5 antagonist with potential immunomodula | ||||
| 184282 | BRD7116 | 329059-55-4 | >98% |  |
| BRD7116 is a potent and selective Inhibitor of leukemia stem cell (LSC) activity (EC5 | ||||
| 18496 | Bazedoxifene acetate | 198480-56-7 | >98% |  |
| Bazedoxifene, also known as WAY-140424, is a third generation selective estrogen rece | ||||
| 184218 | BQR695 | 1513879-21-4 | >98% |  |
| BQR695,也被称为NVP-BQR695, 是一种有效且具有选择性的PI4K抑制剂。 | ||||
| 181242 | BAY1143572 | 1414943-88-6 | >98% |  |
| Atuveciclib，也被称为BAY1143572，是一种具有高度选择性、有效和口服 | ||||
| 181181 | BAY-1436032 | 1803274-65-8 | >98% |  |
| BAY-1436032 is a potent, selective and orally available inhibitor of mutant Isocitrat | ||||
| 17101620 | BGB-283 | 1446090-77-2;1446090-79-4 | >98% |  |
| BGB-283, also known as Beigene-283 or Lifirafenib, is a Novel potent and selective RA | ||||
| 17101619 | Belizatinib | 1357920-84-3 | >98% |  |
| Belizatinib, also known as TSR-011, is an orally available inhibitor of both the rece | ||||
| 1710165 | Bioymifi | 1420071-30-2 | >98% |  |
| Bioymifi is an DR5 activator (Kd = 1.2 µM; IC50 = 2 µM). Bioymifi induces apoptosis | ||||
| 1710162 | BLU-554 | 1707289-21-1 | >98% |  |
| BLU-554 is a fibroblast growth factor receptor 4 (FGFR4) inhibitor potentially for th | ||||
| 1791314 | BX-517 | 850717-64-5 | 98.0% |  |
| BX-517, also known as PDK1 inhibitor2, is a potent and selective PDK1 inhibitor. | ||||
| 179133 | BBT-594 | 882405-89-2 | 98.0% |  |
| BBT594, also known as NVP-BBT594, is potent and selective RET and JAK2 inhibitor. NVP | ||||
| 1791117 | BAY41-4109 racemic | 298708-79-9 | 98.0% |  |
| BAY41-4109 racemic is a mixture of R-isomer of BAY41-4109 and S-isomer of BAY41-4109. | ||||
| 179821 | BAR-501 | 1632118-69-4 | 98.0% |  |
| BAR-501 is a selective GPBAR1 agonist devoid of any FXR agonistic activity. BAR501 ef | ||||
| 179820 | Batefenterol(free base) | 743461-65-6 | 98.0% | -cas-743461-65-6.png) |
| Batefenterol, also known as GSK961081 and TD-5959, is a Muscarinic Antagonist and β2 | ||||
| 83101 | BI-847325 | 1207293-36-4 | 95% |  |
| BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor w | ||||